Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditya Bardia

Showing results (1-10 of 296) with videos related to

Pageof 30
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in metastatic breast cancer from the European Society for Medical Oncology Virtual Congress 2020: commentaryAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Antibody-drug conjugates in breast cancerAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|November 22, 2021
New data for sacituzumab govitecan-hziy in the treatment of metastatic triple-negative breast cancerAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentaryAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|January 6, 2021
A closer look at sacituzumab govitecan-hziyAditya Bardia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2018
Targeted Therapy for Premenopausal Women with HR<sup>+</sup>, HER2<sup>-</sup> Advanced Breast Cancer: Focus on Special Considerations and Latest AdvancesAditya Bardia, Sara Hurvitz
Lancet (London, England)|May 30, 2006
Sex ratio in IndiaAditya Bardia, Krishnan Anand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Personalized tamoxifen: a step closer but miles to goAditya Bardia, Vered Stearns
The Lancet. Oncology|March 19, 2017
SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?Laura Spring, Aditya Bardia
Oncotarget|January 2, 2018
Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncologyNeelima Vidula, Aditya Bardia
Pageof 30

Showing results (1-10 of 296) with videos related to

Sort By:
Pageof 30
Clinical Advances in Hematology & Oncology : H&O|April 12, 2021
Highlights in metastatic breast cancer from the European Society for Medical Oncology Virtual Congress 2020: commentaryAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Antibody-drug conjugates in breast cancerAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|November 22, 2021
New data for sacituzumab govitecan-hziy in the treatment of metastatic triple-negative breast cancerAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|February 5, 2025
Highlights in metastatic breast cancer from the 2024 San Antonio Breast Cancer Symposium: commentaryAditya Bardia
Clinical Advances in Hematology & Oncology : H&O|January 6, 2021
A closer look at sacituzumab govitecan-hziyAditya Bardia
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2018
Targeted Therapy for Premenopausal Women with HR<sup>+</sup>, HER2<sup>-</sup> Advanced Breast Cancer: Focus on Special Considerations and Latest AdvancesAditya Bardia, Sara Hurvitz
Lancet (London, England)|May 30, 2006
Sex ratio in IndiaAditya Bardia, Krishnan Anand
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
Personalized tamoxifen: a step closer but miles to goAditya Bardia, Vered Stearns
The Lancet. Oncology|March 19, 2017
SWISH-ing steroids: new standard of care to prevent everolimus-induced oral mucositis?Laura Spring, Aditya Bardia
Oncotarget|January 2, 2018
Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncologyNeelima Vidula, Aditya Bardia
Pageof 30